<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Dimebon Dimebolin Information Availability &#187; Cholinesterase Inhibitor</title>
	<atom:link href="http://dimebonalzheimers.com/tag/cholinesterase-inhibitor/feed/" rel="self" type="application/rss+xml" />
	<link>http://dimebonalzheimers.com</link>
	<description>Dimebolin Latrepirdine Available Online Pharmacy Internet ?</description>
	<lastBuildDate>Mon, 06 Feb 2012 06:32:20 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.2.1</generator>
		<item>
		<title>Exelon cholinesterase inhibitor</title>
		<link>http://dimebonalzheimers.com/203/exelon-cholinesterase-inhibitor/</link>
		<comments>http://dimebonalzheimers.com/203/exelon-cholinesterase-inhibitor/#comments</comments>
		<pubDate>Fri, 30 Oct 2009 00:38:56 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[Cholinesterase Inhibitor]]></category>
		<category><![CDATA[Exelon]]></category>
		<category><![CDATA[Loss Of Memory]]></category>
		<category><![CDATA[Memory And Thinking]]></category>
		<category><![CDATA[Rivastigmine]]></category>

		<guid isPermaLink="false">http://dimebonalzheimers.vintageomputermanuals.com/?p=203</guid>
		<description><![CDATA[<br /><br />Exelon (Rivastigmine) is a cholinesterase inhibitor used to treat loss of memory and thinking ability associated with Alzheimer&#8216;s Disease. Dimebon Alzheimer’s Disease http://www.dimebonalzheimers.com<br /><br /><br /><br />]]></description>
			<content:encoded><![CDATA[<p></p><p>Exelon (Rivastigmine) is a cholinesterase inhibitor used to treat loss of memory and thinking ability associated with <span class="highlighted">Alzheimer</span>&#8216;s Disease.</p>
<p style="text-align: right;"><a href=" http://www.dimebonalzheimers.com">Dimebon Alzheimer’s Disease</a></p>
<p style="text-align: right;"><a href="http://www.dimebonalzheimers.com">http://www.dimebonalzheimers.com</a></p>
  ]]></content:encoded>
			<wfw:commentRss>http://dimebonalzheimers.com/203/exelon-cholinesterase-inhibitor/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Aricept</title>
		<link>http://dimebonalzheimers.com/201/aricept/</link>
		<comments>http://dimebonalzheimers.com/201/aricept/#comments</comments>
		<pubDate>Sat, 24 Oct 2009 00:34:23 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[Acetyl Cholinesterase]]></category>
		<category><![CDATA[Acetylcholine]]></category>
		<category><![CDATA[Acetylcholinesterase]]></category>
		<category><![CDATA[Aricept]]></category>
		<category><![CDATA[Aricept Donepezil]]></category>
		<category><![CDATA[Cholinergic Neurons]]></category>
		<category><![CDATA[Cholinesterase Inhibitor]]></category>
		<category><![CDATA[Concentration]]></category>
		<category><![CDATA[Hydrolysis]]></category>
		<category><![CDATA[Mechanism Of Action]]></category>
		<category><![CDATA[Reversible Inhibition]]></category>
		<category><![CDATA[Therapeutic Effect]]></category>

		<guid isPermaLink="false">http://dimebonalzheimers.vintageomputermanuals.com/?p=201</guid>
		<description><![CDATA[<br /><br />Aricept (Donepezil), is a centrally acting reversible acetyl cholinesterase inhibitor. Its main therapeutic use is in the treatment of Alzheimer&#8216;s disease where it is used to increase cortical acetylcholine. Donepezil is postulated to exert its therapeutic effect by enhancing cholinergic function. This is accomplished by increasing the concentration of acetylcholine through reversible inhibition of its [...]<br /><br /><br /><br />]]></description>
			<content:encoded><![CDATA[<p></p><p>Aricept (Donepezil), is a centrally acting reversible acetyl cholinesterase inhibitor. Its main therapeutic use is in the treatment of <span class="highlighted">Alzheimer</span>&#8216;s disease where it is used to increase cortical acetylcholine. Donepezil is postulated to exert its therapeutic effect by enhancing cholinergic function. This is accomplished by increasing the concentration of acetylcholine through reversible inhibition of its hydrolysis by acetylcholinesterase. If this proposed mechanism of action is correct, donepezil&#8217;s effect may lessen as the disease process advances and fewer cholinergic neurons remain functionally intact.</p>
  ]]></content:encoded>
			<wfw:commentRss>http://dimebonalzheimers.com/201/aricept/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Cholinesterase Inhibitors &#8211; Their Use and Withdrawl of Treatment</title>
		<link>http://dimebonalzheimers.com/194/cholinesterase-inhibitors-their-use-and-withdrawl-of-treatment/</link>
		<comments>http://dimebonalzheimers.com/194/cholinesterase-inhibitors-their-use-and-withdrawl-of-treatment/#comments</comments>
		<pubDate>Sun, 19 Apr 2009 17:51:42 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[Acetylcholinesterase]]></category>
		<category><![CDATA[Alzheimer Disease]]></category>
		<category><![CDATA[Aricept]]></category>
		<category><![CDATA[Brain Injury]]></category>
		<category><![CDATA[Cholinesterase Inhibitor]]></category>
		<category><![CDATA[Cholinesterase Inhibitors]]></category>
		<category><![CDATA[Cognitive Impairment]]></category>
		<category><![CDATA[Daffodils]]></category>
		<category><![CDATA[Drugs And Medications]]></category>
		<category><![CDATA[Drugs Medications]]></category>
		<category><![CDATA[Exelon]]></category>
		<category><![CDATA[Fetal Alcohol Syndrome]]></category>
		<category><![CDATA[Food And Drug Administration]]></category>
		<category><![CDATA[Galantamine]]></category>
		<category><![CDATA[Moderate Disease]]></category>
		<category><![CDATA[Progressive Disease]]></category>
		<category><![CDATA[Psychiatric Illnesses]]></category>
		<category><![CDATA[Resolution 3d]]></category>
		<category><![CDATA[Target]]></category>
		<category><![CDATA[Withdrawl]]></category>

		<guid isPermaLink="false">http://dimebonalzheimers.vintageomputermanuals.com/?p=194</guid>
		<description><![CDATA[<br /><br />The cholinteresterase inhibitors thus far available&#160; are currently only approved by the F.D.A. (The US Food and Drug Administration)&#160; , are approved by the FDA as only being effective for Alzherimer patients who have thus far mild to moderate disease.&#160; However these drugs and medications &#8211; that is the cholinesterase classification medication grouping, may well [...]<br /><br /><br /><br />]]></description>
			<content:encoded><![CDATA[<p></p><p>The cholinteresterase inhibitors thus far available&nbsp; are currently only approved by the <a title=fda href="http://www.fda.gov/">F.D.A.</a> (The US Food and Drug Administration)&nbsp; , are approved by the FDA as only being effective for Alzherimer patients who have thus far mild to moderate disease.&nbsp; However these drugs and medications &#8211; that is the <a title="cholinteresterase broad classification chemical biological agents" href="cholinesterase">cholinesterase</a> classification medication grouping, may well show promise for those who are in the earliest as well as later stages of the disease , as well.&nbsp; In addition they could well be of benefit and benefits to those with mil cognitive impairment as well.
</p>
<p>One large study evaluated the use of <a title="aricept com" href="http://www.aricept.com/">Aricept</a> (<a title=donepezil href="http://www.medicinenet.com/donepezil/article.htm">dozepezil</a>) in the treatment of mild cognitive&nbsp; impairment and found that it significantly reduced conversion to active Alzheimer&#8217;s progressive disease.
</p>
<p><a href="http://blog.bioasis.ca/?p=853">Current Treatment for Alzheimer’s Disease</a> &#8211; Prescription cholinesterase inhibitors include Exelon and Aricept. These drugs have varying side effects and can have contraindications with other medication, so it can be difficult for doctors to find the right pharmaceutical match and &#8230;
</p>
<p><a href="http://www.freshpatents.com/Methods-and-compositions-using-cholinesterase-inhibitors-dt20090212ptan20090042939.php">Methods and compositions using cholinesterase inhibitors</a> &#8211; The invention provides methods for treating and/or preventing Alzheimer&#8217;s disease, psychiatric illnesses, encephalitis, meningitis, fetal alcohol syndrome, Karsakoff&#8217;s syndrome, anoxic brain injury, cardiopulmonary resuscitation &#8230;
</p>
<p><a href="http://saidfaraj.blogspot.com/2009/03/alzheimer-disease.html">alzheimer disease</a> &#8211; These drugs are called cholinesterase inhibitors because they inhibit the enzymes that break down acetylcholine (acetylcholinesterase and butyrylcholinesterase). Some drugs target only acetylcholinesterase, whereas some target both &#8230;
</p>
<p><a href="http://maynardclark.spaces.live.com/blog/cns!F1B64BFA99EC136!2496.entry">Galantamine: Welsh daffodils containing galantamine may help fight &#8230;</a> &#8211; Galantamine is a competitive and reversible cholinesterase inhibitor. It is believed it works by enhancing cholinergic function by increasing the concentration of acetylcholine in the brain. The atomics resolution 3D structure of the &#8230;
</p>
<p><a href="http://www.ahaf.org/alzheimers/newsupdates/cholinesterase-inhibitors.html">Cholinesterase Inhibitors Reduce Aggression, Wandering And &#8230;</a> &#8211; Cholinesterase Inhibitors Reduce Aggression, Wandering And Paranoia In Alzheimer&#8217;s Disease.
</p>
<p>While cholinesterase inhibitors are now believed to he most helpful in persons with severe Alzheimer&#8217;s disease ,sometimes patients can be maintained on these classes and classifications of drugs indefinitely due to the fact and observation that in clinical practice , that often patients who stop taking these drugs or types of medications deteriorate rapidly when the drugs are arbitrarily stopped or withdrawn.&nbsp; Indeed there is new and upcoming evidence from studies that suggest that stopping cholinesterase inhibitors will result in decline in functioning to a level that the patient would have been at it they &#8211; he or she &#8211; had not been taking the drug in the first place.
</p>
<p>In addition drugs in this class appear to have an added benefit in improving behaviour as well as overall cognitive abilities.
</p>
<p>
<p style="TEXT-ALIGN: right"><a title="Dimebon Alzheimer's Disease" href="http://www.dimebonalzheimers.com/">Dimebon Alzheimer?s Disease</a>
</p>
<p><a href="http://www.modchipcentral.com/">
<p style="TEXT-ALIGN: right">PS3 Mod Chips
</p>
<p>
<p style="TEXT-ALIGN: right"></a><strong><span style="FONT-SIZE: 9pt; COLOR: black; FONT-FAMILY: Arial">
</p>
<p>
<p align=right><strong><span style="FONT-SIZE: 9pt; COLOR: black; FONT-FAMILY: Arial"><a href="http://www.dimebonalzheimers.com/">http://www.dimebonalzheimers.com</a></span></strong>
</p>
<p></span></strong></p>
  ]]></content:encoded>
			<wfw:commentRss>http://dimebonalzheimers.com/194/cholinesterase-inhibitors-their-use-and-withdrawl-of-treatment/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Cholinesterase Inhibitors  in the Treatment of Alzheimer&#039;s Disease</title>
		<link>http://dimebonalzheimers.com/190/cholinesterase-inhibitors-in-the-treatment-of-alzheimers-disease/</link>
		<comments>http://dimebonalzheimers.com/190/cholinesterase-inhibitors-in-the-treatment-of-alzheimers-disease/#comments</comments>
		<pubDate>Fri, 17 Apr 2009 16:40:54 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[Acetylcholine]]></category>
		<category><![CDATA[Aricept]]></category>
		<category><![CDATA[Brain Levels]]></category>
		<category><![CDATA[Chemical Neurotransmitter]]></category>
		<category><![CDATA[Cholinesterase Inhibitor]]></category>
		<category><![CDATA[Cholinesterase Inhibitors]]></category>
		<category><![CDATA[Classification Of Drugs]]></category>
		<category><![CDATA[Cognex]]></category>
		<category><![CDATA[Diarrhea]]></category>
		<category><![CDATA[Drug Medication]]></category>
		<category><![CDATA[Drugs Effects]]></category>
		<category><![CDATA[Liver Toxicity]]></category>
		<category><![CDATA[Loss Of Appetite]]></category>
		<category><![CDATA[Medication]]></category>
		<category><![CDATA[Nausea Vomiting]]></category>
		<category><![CDATA[Neurotransmitter In The Brain]]></category>
		<category><![CDATA[Prescribed Drugs]]></category>
		<category><![CDATA[Reminyl]]></category>
		<category><![CDATA[Stomach Pain]]></category>
		<category><![CDATA[Trade Names]]></category>
		<category><![CDATA[Variants]]></category>
		<category><![CDATA[Variations]]></category>

		<guid isPermaLink="false">http://dimebonalzheimers.vintageomputermanuals.com/?p=190</guid>
		<description><![CDATA[<br /><br />Perhaps the most prescribed category of drugs for Alzhimer&#8217;s disease are the &#8220;Cholinesterase Inhibitor&#8221;  branch.  This group and grouping includes four medications.  Their trade names are &#8220;Aricept&#8221; , &#8220;Cognex&#8221; , &#8220;Excelon&#8221;  and &#8220;Reminyl&#8221;.  This group of medications , specifically the  &#8220;Cholinterase Inhibitors&#8221;   work via a mechanism of raising brain levels of the chemical neurotransmitter in [...]<br /><br /><br /><br />]]></description>
			<content:encoded><![CDATA[<p></p><p>Perhaps the most prescribed category of drugs for Alzhimer&#8217;s disease are the &#8220;Cholinesterase Inhibitor&#8221;  branch.  This group and grouping includes four medications.  Their trade names are &#8220;Aricept&#8221; , &#8220;Cognex&#8221; , &#8220;Excelon&#8221;  and &#8220;Reminyl&#8221;.  This group of medications , specifically the  &#8220;Cholinterase Inhibitors&#8221;   work via a mechanism of raising brain levels of the chemical neurotransmitter in the brain , acetylcholine , that is deficient in people and patients who exhibit the signs , symptoms and progression of Alzheimer&#8217;s Disease and its variants.</p>
<p>It can be said that overall these drugs , and this classification of medications , work to slow the progression of Alzheimer&#8217;s Disease.</p>
<p>In terms of side effects , and the range and variations of side effects with the Cholinesterase classification of drugs  side effects are all pretty similar in their type and range.  This generally includes , nausea , vomiting ,diarrhea , stomach pain, and loss of appetite.  However care must be exhibited with the drug / medication Cognex which can work to effect and cause liver toxicity and toxicities.</p>
<p style="text-align: right;"><a title="Dimebon Alzheimer's Disease" href="http://www.dimebonalzheimers.com/">Dimebon Alzheimer?s Disease</a></p>
<p style="text-align: right;"><strong><span style="font-size: 9pt; color: black; font-family: Arial;"><a href="http://www.dimebonalzheimers.com/">http://www.dimebonalzheimers.com</a></span></strong></p>
  ]]></content:encoded>
			<wfw:commentRss>http://dimebonalzheimers.com/190/cholinesterase-inhibitors-in-the-treatment-of-alzheimers-disease/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

